Pfizer Stock: A Top Bet for 2021?
If you've spent any amount of time hunting for stocks to buy in 2021, Pfizer (NYSE: PFE) and its recently authorized coronavirus vaccine probably caught your attention.
Pfizer and its partner BioNTech (NASDAQ: BNTX) rapidly developed a new vaccine to prevent COVID-19. This is an enormous achievement expected to generate more than $10 billion in top-line sales for the collaboration partners this year, and then sharply taper off in 2022. That's nothing to sneeze at, but it's important to realize Pfizer already expects more than $40 billion in total revenue this year.
Image source: Getty Images.
Source Fool.com


